YOU ARE INVITED
to report on one of
Europe's most important cancer conferences
29th ESMO Congress
Vienna, Austria
29 October-2 November 2004
(Austria Center Vienna)
The 29th ESMO Congress
the biennial conference of the European Society for Medical Oncology
More than 7,000 physicians and scientists will attend over 500 presentations on the latest developments concerning the diagnosis and treatment of cancer, progress in research, and promising new technologies.
International cancer specialists will review progress on important topics such as advances in breast cancer, colorectal cancer, leukaemia, lung cancer, lymphoma, new therapies, pharmacology, prostate cancer, palliative and supportive care, health services, and public health, just to name a few. New treatments involving molecular targets, and combined treatments requiring multidisciplinary approaches will be presented, along with state-of-the-art oncology at its finest.
Some other special features of the Congress:
The first ESMO-Developing Countries Joint Symposium will address disparities of cancer treatment on a global level.
A third ESMO Patient Seminar has been organised to enable patients to meet oncologists on an international scale, and to provide a forum for the discussion of the treatment of cancer.
A Session on ESMO Minimum Clinical Recommendations will update current ESMO guidelines on clinical practice for various tumour types.
Oncology Highlights of the most important advances in cancer treatment in 2004.
Assisting you in Vienna
A Press Center will provide you with information, resources, and expert opinion. Press Conferences will be held, highlighting the most important topics, and you will have access to all the scientific sessions.
Free Media Registration is granted at the Congress to all bona fide media representatives.
A Media Registration Form,
'"/>
Contact: Gracemarie Bricalli
gracemarie@esmo.org
41-091-973-1911
European Society for Medical Oncology 9-Feb-2004Page: 1 2 Related biology news :1.
European common frog found to use novel mating strategy2.
Zoonotic diseases - European scientists unite to fight diseases3.
Second call for proposals for the European Young Investigator Award4.
Common call for action on European Research Council (ERC)5.
EURYI Award given for the first time to 25 young European researchers6.
European researchers tackle mitosis7.
Key principles for the foundation of a European Research Council (ERC)8.
EC boosts European electron microscopy research9.
Plants for the future: A European vision for plant biotechnology towards 202510.
European Commission approves Herceptin + Taxotere as 1st-line therapy in HER2-positive breast cancer11.
Limited climate tracking in European trees despite 10,000 years of postglacial warmth